These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19470407)

  • 1. Comparison of electrocardiographic analysis for risk of QT interval prolongation using safety pharmacology and toxicological studies.
    Guth BD; Bass AS; Briscoe R; Chivers S; Markert M; Siegl PK; Valentin JP
    J Pharmacol Toxicol Methods; 2009; 60(2):107-16. PubMed ID: 19470407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development.
    Markert M; Shen R; Trautmann T; Guth B
    J Pharmacol Toxicol Methods; 2011; 64(1):25-41. PubMed ID: 21635956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmogenic liability screening in cardiovascular safety pharmacology: commonality between non-clinical safety pharmacology and clinical thorough QT (TQT) studies.
    Authier S; Pugsley MK; Troncy E; Curtis MJ
    J Pharmacol Toxicol Methods; 2010; 62(2):83-8. PubMed ID: 20601020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment.
    Tattersall ML; Dymond M; Hammond T; Valentin JP
    J Pharmacol Toxicol Methods; 2006; 53(1):11-9. PubMed ID: 15886026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QT prolongation and safety in the Indian population.
    Dabhi J; Mehta A
    Curr Drug Saf; 2007 Sep; 2(3):200-3. PubMed ID: 18690968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling.
    Malik M; Camm AJ
    Drug Saf; 2001; 24(5):323-51. PubMed ID: 11419561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of group housing on ECG assessment in conscious cynomolgus monkeys.
    Xing G; Lu J; Hu M; Wang S; Zhao L; Zheng W; Schofield J; Oldman K; Adkins D; Yu H; Platz S; Ren J; Skinner M
    J Pharmacol Toxicol Methods; 2015; 75():44-51. PubMed ID: 25979821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug induced shortening of the QT/QTc interval: an emerging safety issue warranting further modelling and evaluation in drug research and development?
    Holbrook M; Malik M; Shah RR; Valentin JP
    J Pharmacol Toxicol Methods; 2009; 59(1):21-8. PubMed ID: 18834945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval - An Analysis of ECGs From the IQ-CSRC Study.
    Darpo B; Benson C; Brown R; Dota C; Ferber G; Ferry J; Jarugula V; Keirns J; Ortemann-Renon C; Pham T; Riley S; Sarapa N; Ticktin M; Zareba W; Couderc JP
    J Clin Pharmacol; 2020 Jan; 60(1):125-139. PubMed ID: 31378962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve.
    Vormberge T; Hoffmann M; Himmel H
    J Pharmacol Toxicol Methods; 2006; 54(2):130-40. PubMed ID: 16757186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT interval correction for drug-induced changes in body temperature during integrated cardiovascular safety assessment in regulatory toxicology studies in dogs: A case study.
    El Amrani AI; El Amrani-Callens F; Loriot S; Singh P; Forster R
    J Pharmacol Toxicol Methods; 2016; 81():136-43. PubMed ID: 27095299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do Studies Evaluating QT/QTc Interval Prolongation with Dietary Supplements Meet FDA Standards: A Systematic Review.
    Nguyen TA; Kurian A; Leong J; Patel UM; Shah SA
    J Diet Suppl; 2017 Jul; 14(4):467-477. PubMed ID: 27937000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT interval prolongation: preclinical and clinical testing arrhythmogenesis in drugs and regulatory implications.
    Giorgi MA; Bolaños R; Gonzalez CD; Di Girolamo G
    Curr Drug Saf; 2010 Jan; 5(1):54-7. PubMed ID: 20210719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the safety assessment of drug-mediated changes in the QT interval... what's next?
    Pugsley MK; Authier S; Towart R; Gallacher DJ; Curtis MJ
    J Pharmacol Toxicol Methods; 2009; 60(1):24-7. PubMed ID: 19616107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced QT Interval Prolongation in the Intensive Care Unit.
    Etchegoyen CV; Keller GA; Mrad S; Cheng S; Di Girolamo G
    Curr Clin Pharmacol; 2017; 12(4):210-222. PubMed ID: 29473523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model.
    Morissette P; Nishida M; Trepakova E; Imredy J; Lagrutta A; Chaves A; Hoagland K; Hoe CM; Zrada MM; Travis JJ; Zingaro GJ; Gerenser P; Friedrichs G; Salata JJ
    J Pharmacol Toxicol Methods; 2013; 68(1):137-49. PubMed ID: 23649000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data-driven drug-induced QT prolongation surveillance using adverse reaction signals derived from 12-lead and continuous electrocardiogram data.
    Choi BJ; Koo Y; Kim TY; Lim HS; Yoon D
    PLoS One; 2022; 17(1):e0263117. PubMed ID: 35100302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead.
    Shah RR
    Drug Saf; 2005; 28(11):1009-28. PubMed ID: 16231954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.